Law ❯ Corporate Law ❯ Securities Regulation

Fraudulent Practices

Investor Protection Litigation Legal Representation Disclosure Obligations Legal Compliance Legal Proceedings Investor Compensation Class Action Lawsuits Litigation Process Whistleblower Protections Legal Recourse Misleading Statements Investor Rights Investigations Prosecution Class Action Settlements Market Manipulation Pump and Dump Schemes Investor Litigation Investor Advocacy Investor Claims Investor Class Actions Disclosure Requirements False Claims

Multiple Firms Vie to Lead Securities Suit Over ADMA Biologics

The chosen lead plaintiff will shape discovery into alleged undisclosed related‑party sales and revenue inflation after a March short‑seller report.

Multiple Law Firms Court Hub Group Investors in Securities Suit

Securities Suit Targets Black Rock Coffee Over Alleged Store Cannibalization

Two National Firms File Class Actions Against PicS Over Alleged IPO Disclosure Failures

Multiple Plaintiff Firms Seek AeroVironment Investors Ahead of July Lead-Plaintiff Deadline

Phreesia Faces Securities Class Action as Firms Race to Be Lead Plaintiff

Veritone Admits Q3 2025 Revenue Accounting Errors and Draws Multiple Investor Lawsuits

Multiple Class Actions Filed Over Culper Short Report as ADMA Investors Face August 10 Lead‑Plaintiff Deadline

Lawsuits Follow Verra Mobility’s Loss of Avis Contract as Firms Vie to Lead Investor Class

Sportradar Faces U.S. Securities Class Action Over Alleged Ties to Black‑Market Betting

Securities Suit Filed Against ADMA Biologics After Short‑Seller Report

Multiple Firms Seek Lead Role in FS KKR Securities Suit as Notices Urge Investors to Act

GeneDx Faces Investor Class Action After Q1 Miss and $31M Fabric Impairment

Class Action Filed Against GRAIL Over NHS‑Galleri Trial Disclosures as Law Firms Seek Lead Plaintiffs

Sportradar Faces U.S. Securities Class Action After Short‑Seller Reports

Law Firm Opens Securities Investigation Into Sleep Number

Multiple Firms Compete to Lead Medpace Securities Suit After Lower Book‑to‑Bill Disclosure

Investors File Securities Suit Against Regencell as Firms Seek Lead Plaintiff

Gartner Investors Urged to Seek Lead-Plaintiff Role as May 18 Deadline Nears

Medpace Investors Face June 8 Deadline To Seek Lead Role in Securities Suit